Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Sustained Tumor Regression With Zenocutuzumab, a Bispecific Antibody Targeting Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 Signaling, in NRG1 Fusion-Positive, Estrogen Receptor-Positive Breast Cancer After Progression on a Cyclin-Dependent Kinase 4/6 Inhibitor.
JCO Precis Oncol. 2022 Aug;6:e2100446. doi: 10.1200/PO.21.00446.
JCO Precis Oncol. 2022.
PMID: 35977350
No abstract available.
Uptake of prostate-specific membrane antigen-targeted 18F-DCFPyL in avascular necrosis of the femoral head.
Torga G, Yin Y, Pomper MG, Pienta KJ, Gorin MA, Rowe SP.
Torga G, et al.
World J Nucl Med. 2019 Dec 18;18(4):416-419. doi: 10.4103/wjnm.WJNM_106_18. eCollection 2019 Oct-Dec.
World J Nucl Med. 2019.
PMID: 31933560
Free PMC article.
Item in Clipboard
Cite
Cite